Letters to the Editor

Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial

Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy;
Stanford School of Medicine, Stanford, CA, USA;
Georgetown University Hospital, Washington D.C., USA;
Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA;
St. James's University Hospital, Leeds, UK;
University of Liverpool, Liverpool, UK;
Memorial Sloan Kettering Cancer Center, New York, NY, USA;
Gilead Sciences, Inc, Foster City, CA, USA;
Dept. I of Internal Medicine, University Hospital of Cologne, Cologne, Germany;
Weill Cornell Medical College, New York, NY, USA
Vol. 105 No. 10 (2020): October, 2020 https://doi.org/10.3324/haematol.2019.238808